Synmosa Biopharma Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Synmosa Biopharma Corp with three other
companies in this sector in Taiwan:
Tci Co Ltd
sales of 2.06 billion Taiwanese Dollars [US$65.40 million]
of which 55%
Nang Kuang Pharmaceutical Co., Ltd
(1.52 billion Taiwanese Dollars [US$48.16 million]
of which 100%
was Medice, Medical Instrument, Trade), and
Sinphar Pharmaceutical C O., Ltd.
(2.19 billion Taiwanese Dollars [US$69.30 million]
of which 66%
Synmosa Biopharma Corp reported sales of 1.78 billion Taiwanese Dollars (US$56.28 million)
December of 2015.
increase of 20.4%
versus 2014, when the company's sales were 1.48 billion Taiwanese Dollars.
Sales at Synmosa Biopharma Corp have increased during each of the previous five years
(and since 2010, sales have increased a total of 115%).